Arunjyoti Bio Ventures Ltd Financials
Company Logo

Arunjyoti Bio Ventures Ltd Financial Statement

Arunjyoti Bio Ventures Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2024
Revenue8.66
Operating Expense7.46
Net Profit1.26
Net Profit Margin14.55
Earning Per Share6.09
EBIDTA2.87
Effective Tax RateTBA

Arunjyoti Bio Ventures Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual1.74
Operating Expenses Annual1.57
Operating Profit Annual0.16
Interest Annual0.00
DepreciationTBA
Net Profit Annual0.12
Tax Annual0.04

Arunjyoti Bio Ventures Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the Beginning0.01
Cash Flow from Operations-13.02
Cash Flow from Investing-19.19
Cash Flow from Financing32.27
Cash Flow at the End0.07

Arunjyoti Bio Ventures Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)9.77
PBIT Margin (%)9.77
PBT Margin (%)-967.24
Net PROFIT Margin (%)6.90
Return On Networth / Equity (%)5.22
Return On Networth /Employed (%)0.92
Return On Assets (%)0.69
Total Debt / Equity (X)7.85
Asset Turnover Ratio (%)0.10

Arunjyoti Bio Ventures Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets AnnualTBA
Total Current Assets Annual5.53
Non Current Assets Annual30.37
Total Shareholders Funds Annual2.12
Total Assets Annual35.91

Arunjyoti Bio Ventures Ltd Earning Calls

EPS (INR)

Expected

0.19

Reported

0.19

Surprise

0.00%

Sep 2010

EPS beaten by 0.00%

Get Your FAQs Right

As of Jul 27, 2024, Arunjyoti Bio Ventures Ltd has a market capitalization of 106.24 Cr. Value Research classifies it as a Micro-Cap company.
No, Arunjyoti Bio Ventures Ltd is not debt-free with a debt-to-equity ratio of 29.10.
In FY 2023 , Arunjyoti Bio Ventures Ltd recorded a total revenue of approximately 20.43 Cr marking a significant milestone in the company's financial performance.
Arunjyoti Bio Ventures Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 1.5% and 1.0% annually, respectively..
Arunjyoti Bio Ventures Ltd's current PE ratio is -303.54.
Arunjyoti Bio Ventures Ltd's ROCE averaged 2.0% from the FY ending March 2022 to 2024, with a median of 1.5%. It peaked at 3.8% in March 2022, reflecting strong capital efficiency over the period..
Arunjyoti Bio Ventures Ltd's latest EBIT is Rs. 0.79 Cr, surpassing the average EBIT of Rs. 0.38 Cr over the 5 years..